KUALA LUMPUR (Feb 2): Pharmaniaga Bhd has obtained extra two million Covid-19 vaccine doses from China s Sinovac Life Sciences Co Ltd, on top of the 12 million that it will supply to the government for Malysian citizens.
Its managing director Datuk Zulkarnain Md Eusope told the media in a virtual briefing that the government had told the pharmaceutical firm to offer the extra two million vaccine doses to economic front liners among the government-linked companies (GLCs), foreign workers and expatriates. In our discussion with the government for the Covid-19 vaccine supply, we have agreed to supply a total of 12 million doses to the government.
KUALA LUMPUR (Feb 2): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Wednesday, Feb 3) include: Boustead Holdings Bhd, Pharmaniaga Bhd, Bursa Malaysia Bhd, RHB Bank Bhd, Greatech Technology Bhd, Genting Malaysia Bhd (GenM), S P Setia Bhd, Lii Hen Industries Bhd, Bintai Kinden Corp Bhd, TCS Group Holdings Bhd, Willowglen MSC Bhd and Westports Holdings Bhd.
Lembaga Tabung Angkatan Tentera (LTAT) has decided not to pursue the privatisation of
Boustead Holdings Bhd at this juncture, after taking into consideration the current challenging economic environment arising from the Covid-19 pandemic and the reimplementation of Movement Control Order.
INTERACTIVE: When to expect your Covid-19 vaccine shots, and everything else you need to know about Malaysia s vaccination programme thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
KUALA LUMPUR: Shares of Pharmaniga Bhd and Duopharma Biotech Bhd climbed in active trade on Wednesday as the companies sign agreement with the Government to supply Covid-19 vaccine.
PETALING JAYA: Malaysia has secured deals to acquire 18.4 million doses of Covid-19 vaccines through Pharmaniaga Bhd
.
In separate announcements, Pharmaniaga said it would be supplying 12 million doses of Covid-19 vaccines developed by China’s Sinovac Life Sciences Co Ltd, while Duopharma said it would supply 6.4 million doses of Sputnik V developed by Russia’s Gamaleya Research Institute to the government.
Both companies yesterday said they had entered into a term sheet agreements to supply the Covid-19 vaccines to the Health Ministry.
Pharmaniaga said it would begin manufacturing Sinovac Covid-19 vaccines in February and will deliver the bottled vaccines to identified hospitals and other healthcare facilities nationwide by April 2021.